HCA Healthcare에 대한 매도 수량은 투자자에게 HCA Healthcare의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

HCA Healthcare (NYSE:HCA) 주식, 공매도 수량 보고

HCA Healthcare

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.

Large Cap

News

Movers

Trading Ideas

ICLR

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 아이콘(NASDAQ:ICLR)의 주식은 예상보다 저조한 실적을 발표한 후 25.95% 급락했다. 여러 애널리스트들도 주가 목표를 하향 조정했다.

제뉴인 파츠 및 탑빌드가 지난주 최악의 성과를 보인 10개 대형주 중 일부 (10월 21일-10월 25일)

Earnings

Pre-Market Outlook

Markets

금요일 아침 (현지 시간 기준) 미국 주식 선물이 약간 높게 거래되면서 오늘 투자자의 관심을 끌 수 있는 일부 주식은 다음과 같다: 1. 월스트리트는 오토네이션(NYSE:AN)이 개장 전 분기별 주당 순이익 $4.38와 매출 $67.1억 달러를 보고할 것으로 예상하고 있다. 오토네이션의 주식은 애프터 마켓에서 0.4% 상승하여 $163.81에 거래되었다.

금요일 주목해야 할 주식: 오토네이션, 캐피털 원, 콜게이트 그리고 2종목

HCA Healthcare Inc

HOLDING CO ADMIE IPTO by Holding Co Admie Ipto SA

Holding Co ADMIE (IPTO) SA

HALO COLLECTIVE INC by HALO COLLECTIVE INC.

Halo Collective Inc

Health Catalyst Inc

On Wednesday, Donald Trump, the Republican candidate and former president, was elected to the highest office again, marking a return to an administration. His second term is likely to impact U.S. healthcare.
Trump has been unclear about his healthcare policy goals during his campaign. Healthcare <a target="_blank" href="https://www.kff.org/health-care-in-2024-elections-apvotecast-polling/?entry=kff-analysis-of-ap-votecast-abortion-ballot-initiatives" rel="noreferrer noopener">ranked</a> lower than issues like the economy and immigration in voter concerns.
A <a target="_blank" href="https://apnews.com/article/ap-votecast-elections-harris-trump-voters-d5cf4e3611f50ec4349d93ddc7f037cd" rel="noreferrer noopener">poll</a> from the Associated Press found that only 8% of voters viewed healthcare as their top issue, compared to 39% who chose the economy and 20% who picked immigration. Abortion was the leading issue for 11% of voters.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction" rel="noreferrer noopener">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a>
Despite his focus on &#8220;Make America Healthy Again,&#8221; millions of Americans may lose health insurance subsidies next year, depending on the political climate after the election and the Republicans&#8217; control of the Senate.
The subsidies, expanded under the 2021 American Rescue Plan, help many, particularly the middle class, afford health insurance through the Affordable Care Act (ACA).
These subsidies are set to expire at the end of 2025, and it remains uncertain whether they will be extended under the new administration.
Trump and other Republicans have opposed continuing the subsidies.
The NBC News <a target="_blank" href="https://www.nbcnews.com/health/health-news/millions-risk-losing-health-insurance-trumps-victory-rcna179146" rel="noreferrer noopener">report</a>, citing some analysts, suggests that the chances of extension could be less than 5% if Republicans win control of the House and the Senate.
Even if Democrats control the House, extending these subsidies seems unlikely. Without an extension, nearly 4 million Americans could lose coverage by 2026 due to unaffordable premiums.
The 2021 changes led to a surge in ACA enrollment, with 15.5 million people benefiting from subsidies across 32 states. The report adds that if the subsidies aren&#8217;t renewed, up to 15.4 million Americans could lose health coverage by 2030.
Another significant issue is Trump&#8217;s stance on Medicare. As president, he supported Medicare Advantage, a private insurer-run program that could eventually replace traditional, government-run Medicare.
The NPR report <a target="_blank" href="https://www.npr.org/sections/shots-health-news/2024/11/07/nx-s1-5183092/trump-election-2024-medicare-advantage" rel="noreferrer noopener">highlights</a> that critics argue that expanding private insurers could increase costs for taxpayers and limit care, with some beneficiaries finding it difficult to switch back to traditional Medicare.
Robert Berenson, a former government official, warned that traditional Medicare could &#8220;wither on the vine.&#8221;
Medicare Advantage grew with the 2003 legislation introducing a drug benefit and expanded private insurers&#8217; role in the program. Although private plans were expected to lower costs, they have been more expensive.
The report also says that in 2023, Medicare Advantage plans cost taxpayers about 6% — or $27 billion — more than traditional Medicare, though some research suggests they offer better care.
The future of healthcare policy in the U.S. will depend on the political dynamics in Congress and Trump&#8217;s second term.
With Republicans pushing for major changes to the ACA and Medicare, experts warn of significant shifts in how Americans access and pay for healthcare in the coming years.
Read Next
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41855578/bristol-myers-squibb-leads-biopharma-recovery-with-almost-25-growth-in-market-cap-but-novo-nordisk-and-lilly-suffer-market-setbacks" target="_blank" rel="noreferrer noopener">Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks</a></li>
</ul>
Photo via Shutterstock

Government

Regulations

Health Care

Politics

General

ALHC

CLOV

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Laboratory Corporation Of America Holdings

Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare

Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Overweight and lowers the price target from $396 to $392.

Price Target

Analyst Ratings

Barclays Maintains Overweight on HCA Healthcare, Lowers Price Target to $392

HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) has outperformed the market over the past 10 years by 6.99% on an annualized basis producing an average annual return of 18.14%. Currently, HCA Healthcare has a market capitalization of $90.29 billion. 
Buying $100 In HCA: If an investor had bought $100 of HCA stock 10 years ago, it would be worth $531.92 today based on a price of $349.86 for HCA at the time of writing.
<h3>HCA Healthcare's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730910641_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today

Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Equal-Weight and raises the price target from $395 to $400.

Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $400

Whales with a lot of money to spend have taken a noticeably bearish stance on HCA Healthcare.
Looking at options history for HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 0% of the investors opened trades with bullish expectations and 90% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $248,630 and 5, calls, for a total amount of $223,750.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $360.0 and $375.0 for HCA Healthcare, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for HCA Healthcare options trades today is 235.5 with a total volume of 1,228.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for HCA Healthcare's big money trades within a strike price range of $360.0 to $375.0 over the last 30 days.
<h3>HCA Healthcare Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730833310_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HCA</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$17.9</td>
<td>$17.2</td>
<td>$17.5</td>
<td>$365.00</td>
<td>$71.7K</td>
<td style="text-align: right;">31</td>
<td style="text-align: right;">52</td>
</tr>
<tr>
<td>HCA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$13.1</td>
<td>$12.7</td>
<td>$12.7</td>
<td>$375.00</td>
<td>$58.4K</td>
<td style="text-align: right;">118</td>
<td style="text-align: right;">91</td>
</tr>
<tr>
<td>HCA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$13.1</td>
<td>$12.6</td>
<td>$12.6</td>
<td>$375.00</td>
<td>$51.6K</td>
<td style="text-align: right;">118</td>
<td style="text-align: right;">178</td>
</tr>
<tr>
<td>HCA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$17.4</td>
<td>$17.0</td>
<td>$17.4</td>
<td>$365.00</td>
<td>$50.4K</td>
<td style="text-align: right;">31</td>
<td style="text-align: right;">122</td>
</tr>
<tr>
<td>HCA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$17.3</td>
<td>$17.0</td>
<td>$17.3</td>
<td>$365.00</td>
<td>$46.7K</td>
<td style="text-align: right;">31</td>
<td style="text-align: right;">149</td>
</tr>
</tbody>
</table>

<h3>About HCA Healthcare</h3>
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
In light of the recent options history for HCA Healthcare, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is HCA Healthcare Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 467,360, the HCA's price is down by 0.0%, now at $363.16. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 84 days.</li>
</ul>
<h3>What The Experts Say On HCA Healthcare</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $426.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Keybanc continues to hold a Overweight rating for HCA Healthcare, targeting a price of $420. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on HCA Healthcare, which currently sits at a price target of $400. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for HCA Healthcare, targeting a price of $395. 
&#x2A; An analyst from TD Cowen has decided to maintain their Buy rating on HCA Healthcare, which currently sits at a price target of $440. 
&#x2A; Reflecting concerns, an analyst from Keybanc lowers its rating to Overweight with a new price target of $475.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest HCA Healthcare options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Looking At HCA Healthcare's Recent Unusual Options Activity

TD Cowen analyst Gary Taylor maintains HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Buy and lowers the price target from $450 to $440.

TD Cowen Maintains Buy on HCA Healthcare, Lowers Price Target to $440

Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Overweight and lowers the price target from $475 to $420.

Keybanc Maintains Overweight on HCA Healthcare, Lowers Price Target to $420

Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Outperform and raises the price target from $390 to $400.

Oppenheimer Maintains Outperform on HCA Healthcare, Raises Price Target to $400

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Friday.
U.S. stocks settled mixed on Friday, with the Nasdaq Composite surging to an all-time high during the session.
Tech stocks provided a boost to the market ahead of their upcoming quarterly earnings. Shares of Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), and Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAZN#NASDAQ">AMAZN</a>) settled higher on Friday.
Both the Dow Jones and S&amp;P 500 ended a six-week winning streak, falling around 1% and 2.7%, respectively. The Nasdaq recorded gains for the seventh straight week, gaining nearly 0.2% last week.
Shares of HCA Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) fell around 9% on Friday after the company reported weaker-than-expected third-quarter financial results. Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) shares fell around 4% after the company reported third-quarter earnings.
On the economic data front, the University of Michigan consumer sentiment for the U.S. rose to 70.5 in October compared to a preliminary reading of 68.9. U.S. durable goods orders fell by 0.8% to $284.8 billion in September compared to a revised 0.8% fall in August.
Most sectors on the S&amp;P 500 closed on a negative note, with financials, real estate, and utilities stocks recording the biggest losses on Friday. However, information technology and communication services stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 260 points to 42,114.40 on Friday. The S&amp;P 500 fell 0.03% to 5,808.12, while the Nasdaq Composite climbed 0.56% at 18,518.61 during Friday's session.
Investors are awaiting earnings results from ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>), Waste Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>), and Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 58.9, the index remained in the &#8220;Greed&#8221; zone on Friday, versus a prior reading of 61.5.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41545103/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-delivering-high-dividend">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

AMAZN

NVDA

Nasdaq Surges To Fresh Highs As Nvidia, Meta And Amazon Register Gains: Fear Index Remains In 'Greed' Zone

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>ICON plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) shares plummeted 25.95% after the company reported <a href="https://www.benzinga.com//node/41500867" target="_blank" rel="noreferrer noopener">worse-than-expected results</a>. Several analysts also cut the <a href="https://www.benzinga.com/quote/iclr/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) stock tumbled 20.21% after it reported mixed third-quarter results and cut its <a href="https://www.benzinga.com//node/41455012" target="_blank" rel="noreferrer noopener">FY24 EPS below estimates</a>. Multiple analysts cut the <a href="https://www.benzinga.com/quote/gpc/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) shares dipped 15.97% after the company reported <a href="https://www.benzinga.com//node/41503948" target="_blank" rel="noreferrer noopener">third-quarter financial results</a>. Analysts trimmed the <a href="https://www.benzinga.com/quote/nem/analyst-ratings" target="_blank" rel="noreferrer noopener">stock&#8217;s price target</a>.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) stock lost 14.71% last week. Several healthcare stocks and hospital operators fell in possible sympathy with HCA Healthcare, which declined on Q3 earnings.</li>
<li>Universal Health Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) stock fell 14.33% last week after the company reported <a href="https://www.benzinga.com//node/41530333" target="_blank" rel="noreferrer noopener">Q3 financial results</a>.</li>
<li>HCA Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) stock fell 12.51% after reporting <a href="https://www.benzinga.com//node/41544243" target="_blank" rel="noreferrer noopener">worse-than-expected Q3 financial results</a>. The company expects Hurricane Helene&#8217;s impact to continue in 2025.</li>
<li>TopBuild Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLD#NYSE">BLD</a>) stock lost 11.48% last week as homebuilding stocks <a href="https://www.benzinga.com//node/41317881" target="_blank" rel="noreferrer noopener">took a beating</a> due to Hurricane Milton&#8217;s impact.</li>
<li>Carlisle Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>) fell 11.45% last week on <a href="https://www.benzinga.com//node/41529849" target="_blank" rel="noreferrer noopener">worse-than-expected Q3 performance</a>.</li>
<li>Teradyne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) stock declined 11.34% after it reported <a href="https://www.benzinga.com//node/41503363" target="_blank" rel="noreferrer noopener">third-quarter financial results</a>. Some analysts trimmed the <a href="https://www.benzinga.com/quote/ter/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Comfort Systems USA, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) stock declined 11.27% after the company reported <a href="https://www.benzinga.com//node/41530044" target="_blank" rel="noreferrer noopener">worse-than-expected Q3 sales results</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/10/41560908/tesla-li-auto-and-microstrategy-are-among-top-10-large-cap-gainers-last-week-oct-21-oct-25-are-the">Tesla, Li Auto And MicroStrategy Are Among Top 10 Large Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?</a></li>
</ul>

Genuine Parts Company, Universal Health Services, And TopBuild Are Among Top 10 Large Cap Losers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?

Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week&#8217;s pivotal earnings releases from <a href="https://www.benzinga.com/topic/magnificent-7">five of the &#8220;Magnificent Seven&#8221; stocks.</a>
Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>), Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) will all report quarterly earnings between Oct. 29 and Oct. 31.
Combined, nearly 45% of the S&amp;P 500 by market cap is set to report results next week, with other heavyweights including McDonald&#8217;s Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), Mastercard Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) and Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>).
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) continued its upward trajectory on Friday, rising 2.7% following a massive 21% jump on Thursday — its biggest one-day gain since May 2013.
The S&amp;P 500 was up 0.5% at midday trading in New York, while the Nasdaq 100 surged by 1.5%, fueled by semiconductor stocks. 
The Dow Jones Industrial Average fell 0.3%, on track to end a six-week winning streak. The U.S. dollar strengthened further, with the DXY Index rising past the 104 mark, setting up for a fourth straight week of gains. Meanwhile, Treasury yields were steady. 
WTI crude rose 1.8%, driven by concerns over geopolitical tensions in the Middle East. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is up slightly at $67,695.
<h1 class="wp-block-heading">Friday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % change</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,500.56</td>
<td>1.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,839.28</td>
<td>0.5%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,219.60</td>
<td>0.3%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,271.11</td>
<td>-0.3%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:50 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent102225&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.5% to $582.19.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;eased 0.2% to $423.18.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rallied 1.3% to $498.83.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.2% up to $220.09.</li>
<li>The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up by 1.4%. The Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) lagged, down 0.9%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
<ul>
<li>Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) rallied 7% to levels last seen in October 2021 on better-than-expected quarterly results. </li>
<li>Digital Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) rallied over 10% after reporting record new lease bookings. </li>
</ul>
Other stocks reacting to earnings included:
<ul>
<li>Ameriprise Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>), down 0.13%</li>
<li>DexCom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>), down 1%</li>
<li>ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) up 7.6%, </li>
<li>Skechers U.S.A. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) down 0.2%, </li>
<li>Western Digital Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) up 7.6%, </li>
<li>Deckers Outdoor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>), up 11%</li>
<li>Edward Lifesciences Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>), down by 0.6%</li>
<li>HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), down 10%, </li>
<li>Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>), up 6%, </li>
<li>Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), down 3.4%, </li>
<li>Centene Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>), up 6.7%, </li>
<li>Saia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>), up 9.2%. </li>
</ul>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41549147/goldman-sachs-analyst-remains-bullish-on-boeing-despite-weak-q3-long-term-deep-valu">Goldman Sachs Analyst Remains Bullish On Boeing Despite Weak Q3: &#8216;Long-Term Deep-Value Opportunity</a>&#8216;</li>
</ul>
Photo: Shutterstock

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

ETFs

$BTC

AAPL

AMZN

DECK

SPDR Dow Jones Industrial Average ETF Trust

DXCM

GOOG

GOOGL

MSFT

RIVN

SAIA

TSLA

Select Sector SPDR-Consumer Discretionary

Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?

On Tuesday, HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) reported third-quarter revenues of $17.49 billion, up 7.9% year-over-year, slightly missing the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $17.54 billion</a>.
The hospital chain reported adjusted EPS of $4.90, up from $3.91 a year ago, missing the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41541557/hca-healthcare-reports-third-quarter-2024-results" rel="noreferrer noopener">consensus of $4.96</a>.
In the third quarter of 2024, same-facility admissions increased 4.5% year over year, while same-facility equivalent admissions increased 4.5%.
Same-facility emergency room visits increased by 4.6%, same-facility inpatient surgeries increased by 1.6%, and same-facility outpatient surgeries declined by 2.0%.
Same facility revenue per equivalent admission increased by 2.5%.
For the third quarter of 2024, adjusted EBITDA totaled $3.27 billion, compared to $2.88 billion a year ago.
Guidance:&nbsp;HCA Healthcare reaffirmed its 2024 estimated guidance ranges. Given the ongoing impact of the two major hurricanes on the remainder of the year, the company estimates that results will likely be in the lower half of the ranges provided.
During its second-quarter earnings release, the company revised its fiscal year 2024 revenue guidance to $69.75 billion—$71.75 billion, compared to prior guidance of $67.75 billion—$70.25 billion and <a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/39913930/hospital-chain-operator-hca-healthcare-says-positive-q2-earnings-reflect-strong-demand-for-services" rel="noreferrer noopener">the consensus of&nbsp;$70.91 billion</a>.
The company forecasts 2024 EPS&nbsp;guidance&nbsp;of&nbsp;$21.60-22.80, up from the prior guidance of $19.70-$21.20&nbsp;and the consensus of&nbsp;$22.62.
The company expects 2024 adjusted EBITDA of $12.85 billion—$13.55 billion, versus the prior guidance of $13.75 billion—$14.25 billion.
During the fourth quarter of 2024, the company anticipates ongoing additional expenses and revenue losses due to Hurricane Helene's impact on its North Carolina facilities and Hurricane Milton, which impacted certain facilities in Florida during October, of approximately $200 to $300 million, or $0.60 to $0.90 per diluted share.
HCA Healthcare anticipates some ongoing impact in 2025 from Hurricane Helene on its North Carolina facilities.
The company believes these ongoing effects will be manageable and expects 2025 diluted EPS and Adjusted EBITDA growth to be near or slightly above the upper end of its long-term growth ranges.
Price Action:&nbsp;HCA Healthcare stock is down 8.95% at $363.19&nbsp;during the premarket session at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41542651/centene-says-it-is-positioned-to-capture-long-term-growth-in-government-sponsored-healthcare-lifts-" target="_blank" rel="noreferrer noopener">Centene Says It Is Positioned To Capture Long-Term Growth In Government-Sponsored Healthcare, Lifts Annual Outlook</a></li>
</ul>
Photo via Company

Guidance

HCA Healthcare Q3 Earnings: Revenue And Profit miss, Sees Hurricane Impact on Q4 and FY25 Earnings Growth

WIIM

HCA Healthcare shares are trading lower after the company reported worse-than-expected Q3 financial results and announced it expects some ongoing impact in 2025 from Hurricane Helene.

The Company believes these ongoing effects will be manageable and currently expects 2025 diluted earnings per share and Adjusted EBITDA growth to be near, or slightly above, the upper end of its long-term growth ranges.

HCA Healthcare Anticipates Some Ongoing Impact In 2025 From Hurricane Helene On Its North Carolina Facilities

HCA Healthcare Q3 2024 Adj. EPS $4.90 Misses $4.96 Estimate, Sales $17.487B Miss $17.538B Estimate

Investors could see a second straight day of an opening in the green on Wall Street as the index futures point to a positive start on Friday. Treasury yields started cooling again after scaling three-month highs.
While Friday is a little light on the earnings side, consumer sentiment data and a speech by Boston Fed President Susan Collins could set the tone for the markets for the last day of the week.
All three major indices could close in the red for this week after surging for six consecutive weeks.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.27%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.26%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.23%</td>
</tr>
<tr>
<td>R2K</td>
<td>0.56%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Thursday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.30% to $580.95 and the Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) surged 0.32% to $493.91, according to<a href="https://benzinga.grsm.io/lxquj26b2sag"> Benzinga Pro data</a>.
Cues From Last Session:
EV giant Tesla Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares witnessed their best single-day gain in over a decade after the Elon Musk-led EV giant blew past expectations.
A tightly packed week of earnings is now drawing to a close, with nearly a third of S&amp;P 500 companies having reported their results. According to FactSet data, more than 70% of these companies have managed to beat expectations in terms of profits.
The S&amp;P 500 ended its 3-day losing streak while the Nasdaq Composite maintained its momentum on the back of Tesla and other tech stocks.
On the economic data front, U.S. initial jobless claims declined by 15,000 from the prior week to 227,000 during the period ending Oct. 19, compared to market estimates of 242,000.
Most sectors on the S&amp;P 500 closed on a negative note, with materials, industrials, and utilities stocks recording the biggest losses on Thursday. However, consumer discretionary and communication services stocks bucked the overall market trend, closing the session higher.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.76%</td>
<td>18,415.49</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.21%</td>
<td>5,809.86</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.33%</td>
<td>42,374.36</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.23%</td>
<td>2,218.92</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Following six consecutive weeks of gains, the markets have remained gloomy this week, with tech stocks offering some respite amid sideways movements in most other sectors.
Benchmark US 10-year treasury yields continued to cool down after scaling three-month highs.
On the economic data front, the S&amp;P Global flash manufacturing PMI rose to 47.8 in October versus a 15-month low level of 47.3 in September, while services PMI increased to 55.3 in October from 55.2 in the prior month.
"The election itself can be a bit of a hairy situation. I think right now, although the market sort of has been pricing in some Trump trades, I think the polls are still telling you that it&#8217;s a coin toss," Interactive Brokers chief strategist Steve Sosnick <a href="https://finance.yahoo.com/video/3-things-could-cause-market-213000687.html">said</a> in an interview with Market Domination.
On the other hand, despite the Tesla stock "firing on all cylinders" and turning positive year-to-date after Thursday's rally, fund manager Louis Navellier thinks the EV giant still <a href="https://investorplace.com/market360/2024/10/teslas-earnings-boost-stock-amid-robotaxi-innovations/">has</a> to improve its fundamentals before going long on the stock.
"Now is not a good time to buy Tesla. I would wait for its fundamentals to improve further before investing in the company."
See Also:<a href="https://www.benzinga.com/money/best-futures-trading-software"> Best Futures Trading Software</a>
Upcoming Economic Data:
<ul>
<li>Data on durable goods orders is scheduled to be released at 8:30 a.m. ET.</li>
<li>Data on consumer sentiment is scheduled to be released at 10 a.m. ET.</li>
<li>University of Michigan (UoM) is scheduled to release one and five-year inflation expectations at 10 a.m. ET.</li>
<li>Boston Fed President Susan Collins is scheduled to speak at 11 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Tesla will stay in focus after the stock registered its best single-day gains in over a decade, a day after beating margin and EPS estimates in its third-quarter earnings.</li>
<li>Capri Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) tumbled over 46% in premarket trading after a judge blocked its acquisition by fashion group Tapestry Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>).</li>
<li>Spirit Airlines Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) stock surged over 11% in premarket trading after the carrier announced the sale of 23 Airbus A320 aircraft worth $519 million. It also announced job cuts.</li>
</ul>
Investors are awaiting earnings results from&nbsp;AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>), Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), and HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) today.
Commodities, Bonds And Global Equity Markets:
Crude oil futures rose in the early New York session, surging nearly 0.7% as data showed a rise in spot demand.
The 10-year Treasury note yield eased marginally to 4.198%.
Asian markets were mixed on Thursday, with Chinese markets rising marginally while Japan's Nikkei 225 registering a decline.
European stocks remained tentative in early trading, concluding what has been a gloomy week so far.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41539590/tesla-shares-slip-in-pre-market-a-day-after-massive-22-rally-whats-going-on">Tesla Shares Slip In Pre-Market A Day After Massive 22% Rally: What&#8217;s Going On?</a></li>
</ul>
Photo courtesy: Shutterstock

Futures

Previews

Federal Reserve

CPRI

SAVE

US Stocks Set To Rise As Treasury Yields Ease, Tesla, Spirit Airlines Among Stocks In Focus: Fund Manager Says Despite Elon Musk's Company 'Firing On All Cylinders,' It's Still Not A 'Good Time To Buy'

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Thursday.
U.S. stocks settled mixed on Thursday, with the S&amp;P 500 recording its first positive session in a week.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) was the top-performing stock in the index. Shares of the company jumped around 22% on Thursday after reporting stronger-than-expected third-quarter earnings. International Business Machines Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) shares fell 6.2% following a third-quarter revenue miss.
On the economic data front, U.S. initial jobless claims declined by 15,000 from the prior week to 227,000 during the period ending Oct. 19, compared to market estimates of 242,000. The S&amp;P Global flash manufacturing PMI rose to 47.8 in October versus a 15-month low level of 47.3 in September, while services PMI increased to 55.3 in October from 55.2 in the prior month.
Most sectors on the S&amp;P 500 closed on a negative note, with materials, industrials, and utilities stocks recording the biggest losses on Thursday. However, consumer discretionary and communication services stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 141 points to 42,374.36 on Thursday. The S&amp;P 500 rose 0.21% to 5,809.86, while the Nasdaq Composite climbed 0.76% to close at 18,415.49 during Thursday's session.
Investors are awaiting earnings results from AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>), Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), and HCA Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 63.4, the index remained in the &#8220;Greed&#8221; zone on Thursday, versus a prior reading of 62.3.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41516113/how-to-earn-500-a-month-from-weyerhaeuser-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Weyerhaeuser Stock Ahead Of Q3 Earnings</a></li>
</ul>
Photo courtesy: Shutterstock

S&P 500's 3-Day Losing Streak Ends Following Jump In Tesla Shares: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

With U.S. stock futures trading slightly higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) to report quarterly earnings at $4.38 per share on revenue of $6.71 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. AutoNation shares gained 0.4% to $163.81 in after-hours trading.</li>
<li>Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) reported better-than-expected third-quarter results.&nbsp; The company reported quarterly earnings of $4.51 per share, which beat the analyst consensus estimate of $3.76. Quarterly revenue came in at $10.014 billion, which beat the analyst consensus estimate of $9.861 billion. Capital One Financial shares climbed 4.9% to $160.71 in the after-hours trading session.</li>
<li>Analysts are expecting Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) to post quarterly earnings at 89 cents per share on revenue of $5.00 billion. The company will release earnings before the markets open. Colgate-Palmolive shares gained 0.7% to $100.40 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Edwards Lifesciences Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) reported better-than-expected earnings for the third quarter, while sales missed estimates. Edwards Lifesciences shares fell 4.4% to $67.25 in the after-hours trading session.</li>
<li>Analysts expect HCA Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) to report quarterly earnings at $4.96 per share on revenue of $17.54 billion before the opening bell. HCA Healthcare shares fell 1% to $395.00 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41516113/how-to-earn-500-a-month-from-weyerhaeuser-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Weyerhaeuser Stock Ahead Of Q3 Earnings</a></li>
</ul>
Photo courtesy: AutoNation

AutoNation, Capital One Financial And 3 Stocks To Watch Heading Into Friday

Deep-pocketed investors have adopted a bearish approach towards HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HCA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 30 extraordinary options activities for HCA Healthcare. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 40% leaning bullish and 60% bearish. Among these notable options, 13 are puts, totaling $584,901, and 17 are calls, amounting to $1,026,933.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $120.0 to $430.0 for HCA Healthcare over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for HCA Healthcare's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of HCA Healthcare's whale activity within a strike price range from $120.0 to $430.0 in the last 30 days. 
<h3>HCA Healthcare Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729798233_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HCA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$8.1</td>
<td>$7.1</td>
<td>$7.3</td>
<td>$430.00</td>
<td>$219.0K</td>
<td style="text-align: right;">314</td>
<td style="text-align: right;">308</td>
</tr>
<tr>
<td>HCA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$15.6</td>
<td>$15.2</td>
<td>$15.2</td>
<td>$390.00</td>
<td>$118.5K</td>
<td style="text-align: right;">215</td>
<td style="text-align: right;">70</td>
</tr>
<tr>
<td>HCA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$104.6</td>
<td>$99.6</td>
<td>$104.6</td>
<td>$310.00</td>
<td>$104.6K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">10</td>
</tr>
<tr>
<td>HCA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$25.5</td>
<td>$24.1</td>
<td>$25.5</td>
<td>$390.00</td>
<td>$99.4K</td>
<td style="text-align: right;">113</td>
<td style="text-align: right;">49</td>
</tr>
<tr>
<td>HCA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$15.3</td>
<td>$14.3</td>
<td>$15.3</td>
<td>$410.00</td>
<td>$71.9K</td>
<td style="text-align: right;">505</td>
<td style="text-align: right;">276</td>
</tr>
</tbody>
</table>

<h3>About HCA Healthcare</h3>
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
After a thorough review of the options trading surrounding HCA Healthcare, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of HCA Healthcare</h3>
<ul>
<li>Currently trading with a volume of 1,490,984, the HCA's price is down by -1.26%, now at $404.88. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 1 days.</li>
</ul>
<h3>What Analysts Are Saying About HCA Healthcare</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $413.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for HCA Healthcare, targeting a price of $395. 
&#x2A; In a cautious move, an analyst from Keybanc downgraded its rating to Overweight, setting a price target of $475. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $392. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $392. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for HCA Healthcare with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Check Out What Whales Are Doing With HCA

HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) is preparing to release its quarterly earnings on Friday, 2024-10-25. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect HCA Healthcare to report an earnings per share (EPS) of $4.96.
HCA Healthcare bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.62, leading to a 1.11% increase in the share price on the subsequent day.
Here's a look at HCA Healthcare's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>4.88</td>
<td>5.01</td>
<td>5.04</td>
<td>3.99</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>5.50</td>
<td>5.36</td>
<td>5.90</td>
<td>3.91</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729778509_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of HCA Healthcare were trading at $410.03 as of October 23. Over the last 52-week period, shares are up 79.21%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/HCA/earnings">To track all earnings releases for HCA Healthcare visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For HCA Healthcare

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on HCA Healthcare (HCA – Research Report) today and set a price target of $400.00. T...

HCA Healthcare (HCA) Receives a Rating Update from a Top Analyst

Oppenheimer raised the firm's price target on HCA Healthcare (HCA) to $400 from $390 and keeps an Outperform rating on the shares. The firm notes H...

HCA Healthcare price target raised to $400 from $390 at Oppenheimer

Call overwriting and call buying opportunities within the Russell 1000 – JPM

Healthcare services stocks could benefit from Harris win, Oppenheimer says

Top 50 High-Quality Dividend Growth Stocks - October 2024 Results

Wells Fargo raised the firm's price target on HCA Healthcare (HCA) to $400 from $395 and keeps an Equal Weight rating on the shares. Following Q3 e...

HCA Healthcare price target raised to $400 from $395 at Wells Fargo

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on HCA Healthcare (HCA – Research Report), Exact Scie...

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Exact Sciences (EXAS) and Crispr Therapeutics AG (CRSP)

Hospital stocks could see negative impact under Trump

Trump re-election: KeyBanc says watch these health and consumer stocks

In a report released today, Joanna Gajuk from Bank of America Securities maintained a Buy rating on HCA Healthcare (HCA – Research Report). The com...

Bank of America Securities Reaffirms Their Buy Rating on HCA Healthcare (HCA)

ACHC

ADUS

ALLE

AMAT

ARDT

ASTH

CRSP

CTAS

DLTR

EXAS

FAST

FHLC

FIVE

FRPT

GRMN

HOOD

IBUY

INNV

ISHP

JKHY

KLAC

LECO

LRCX

MKTX

MPWR

MSCI

NTES

NXPI

ODFL

ONLN

OSCR

PAYX

PLTR

POOL

PRVA

QCOM

RACE

ROST

SBUX

SCHD

SOFI

TSCO

UPBD

Press Releases

HCA Announces Proposed Public Offering of Senior Notes

HCA Healthcare, Inc. to Present at September Healthcare Conferences

HCA Healthcare Presents 2024 Awards of Distinction

HCA Healthcare, Inc. 3rd Quarter 2024 Earnings Conference Call

HCA Healthcare to Donate $1 Million Towards Hurricane Helene Disaster Relief Efforts in North Carolina

HCA Healthcare, Inc. to Present at November Healthcare Conferences

HCA Healthcare to Host Sixth Annual "Crush the Crisis" National Prescription Drug Take Back Day

HCA Healthcare Reports Third Quarter 2024 Results

HCA Healthcare Named a Best Employer for Veterans by Military Times for Fifth Consecutive Year

The Frist Foundation Gives $1 Million to the HCA Healthcare Hope Fund in Support of HCA Healthcare Colleagues Impacted by Hurricanes Helene and Milton

Comments

HCA Healthcare

매도 수량

HCA Healthcare (NYSE:HCA) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌